跳至主要内容
临床试验/NCT04363710
NCT04363710已完成不适用

Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Max Healthcare Insititute Limited1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2017年5月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
33
试验地点
1
主要终点
Fasting Blood Glucose in millimoles per liter and Fasting Insulin Level in picomole per liter will be combined to report HOMA IR

研究概览

简要总结

T2DM, a chronic progressive disorder has an epidemic status in India. Remission (HbA1c of < 6.5% without any anti-diabetic medication) of T2DM is achievable with diet modifications in recently diagnosed obese T2D individuals. Studies suggest Very Low Calorie Diet (600 - 800kcal) and Low Calorie Diet-LCD (800 -1000 kcal) using Meal replacers (MR) are helpful. The investigators aimed to study the effects of LCD without any anti diabetic medication in intervention group and later comparing it with Control group (on standard medical treatment).

详细描述

The objective is to study the effect of LCD in anthropometric , biochemical and NAFLD (Non Alcholic Fatty Liver Disease) parameters after 8 weeks and 24 weeks from enrollment.

Purposive sampling is used to enroll participants in the study. The LCD is a combination of one meal replacer and modified major meals. Calculated exchanges of food groups is taken care of in the other two major meals and snacks in between. Inorder to adhere compliance clinical (at baseline, after 8 weeks, after 24 weeks) as well as virtual visits through whatsapp, e-mails, SMS, phone calls (once a week during 8 weeks of intervention and further once a month upto 24 weeks) are scheduled. After 8 weeks of LCD, calorie is increased to 1200-1400 Kcal/day. In the control group the standard medical treatment is continued.

The data is collected in case report form and analysed using SPSS software by statistician.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with BMI ≥ 30 kg/m^2
  • •DM history of less than 6 years.
  • •HBA1C of 6.5-8.5 %.
  • •On two or less than two diabetes medication.

排除标准

  • •Patients on Insulin
  • •Patients having any co morbidity like severe diabetic nephropathy, neuropathy and any other serious illness.
  • •Evidence of Type 1 diabetes, ketones and acidosis.

研究组 & 干预措施

Intervention group

Experimental

Participants in this arm were advised intervention of Low Calorie Diet (800-1000 Kcal/day) for 8 weeks without any anti diabetic medication

干预措施: Low Calorie Diet (Other)

Control Group

No Intervention

Participants in this arm were kept on their standard medical treatment

结局指标

主要结局

Fasting Blood Glucose in millimoles per liter and Fasting Insulin Level in picomole per liter will be combined to report HOMA IR

时间窗: up to 24 weeks

To achieve normal HOMA IR range

HbA1c in percentage

时间窗: up to 24 weeks

To bring HbA1c below diagnostic criteria of type 2 diabetes mellitus as per ADA 2020

Weight in kilogram and height in meters will be combined to report BMI in Kg/m^2

时间窗: up to 24 weeks

when obese T2D individuals will have significant improvement in BMI

次要结局

未报告次要终点

研究者

发起方
Max Healthcare Insititute Limited
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验